The Pulsatile Mitochondrial Fission-ROS (PMFR) Hypothesis: Why Amplitude and Frequency, Not Baseline Levels, Govern Mitohormesis

The "antioxidant paradox" is no longer a paradox if we stop viewing reactive oxygen species (ROS) as a homogeneous cellular pool. We know that exogenous antioxidants often fail to extend lifespan—and can even accelerate mortality. For instance, meta-analyses of over 230,000 subjects demonstrate that vitamins A, E, and beta-carotene increase mortality risk, and dietary antioxidants paradoxically shortened lifespan in voles despite reducing lipid peroxidation.

I propose the Pulsatile Mitochondrial Fission-ROS (PMFR) Hypothesis: The longevity benefits of mitohormesis are not dependent on steady-state ROS concentrations, but rather on the amplitude and frequency of localized ROS pulses generated precisely during mitochondrial fission events. Exogenous antioxidants fail because they indiscriminately blunt the amplitude of these spatial pulses below the threshold required for stress-response activation.

Mechanistic Rationale

Recent data shows that ubiquitous overexpression of mitochondrial fusion genes paradoxically increases fragmentation yet enhances stress resilience and extends longevity. This apparent contradiction resolves if we view fragmentation (fission) as a generator of transient, high-amplitude ROS "nanodomains." When mitochondria undergo fission, localized membrane depolarization briefly spikes superoxide and hydrogen peroxide emission.

These acute nanodomain spikes are mechanistically essential. To activate longevity pathways like the Sty1 MAP kinase cascade or Nrf2, which drives proteostasis across species, ROS must reach a high enough localized concentration to oxidize specific, low-reactivity cysteine residues (e.g., on Keap1). Furthermore, AMPK, which links dietary restriction to FOXO/DAF-16 and directly phosphorylates Nrf2 at Ser50 to drive mitohormesis, requires precise spatio-temporal redox triggers.

Continuous, low-level "leak" ROS—characteristic of pathological aging—fails to trigger these sensors because basal cellular reductants (thioredoxin/glutathione) easily buffer it. Conversely, high-dose exogenous antioxidants act as a systemic sink, "flattening the curve" of fission-induced ROS pulses. They prevent the nanodomain amplitude from reaching the Keap1/AMPK activation threshold, effectively silencing the cell's adaptive signaling while leaving basal mitochondrial dysfunction intact.

Testable Predictions

This hypothesis moves away from measuring bulk ROS and demands spatial-temporal resolution. It can be falsified through the following experiments:

1. Fission-Dependency of Hormesis: If mild oxidative stress (e.g., via calorie restriction or paraquat) extends lifespan by inducing ROS pulses during fission, then inhibiting mitochondrial fission (via Drp1 knockdown or Mdivi-1 treatment) should abolish Nrf2/AMPK activation and lifespan extension, even if total cellular ROS levels are artificially maintained.
2. Amplitude Blunting by Supplements: Using genetically encoded redox biosensors (e.g., mitochondria-targeted roGFP) with high-speed confocal microscopy, we should observe discrete ROS spikes perfectly co-localized with fission events. Treatment with alpha-tocopherol (Vitamin E) will selectively reduce the peak amplitude of these spikes without significantly altering the steady-state baseline, directly correlating with a failure to oxidize Keap1.
3. Optogenetic Rescue: Optogenetically generating pulsatile, high-amplitude ROS bursts in the mitochondria (using KillerRed or similar photosensitizers) at physiological fission frequencies will induce greater Nrf2-mediated longevity than generating the exact same total sum of ROS delivered as a continuous, low-intensity baseline.

To advance redox biology, we must stop treating the cell as a well-mixed beaker. ROS signaling is a frequency-modulated language; antioxidants are just static noise masking the signal.